Latest News

The success of Forex trading comes down to timing, and understanding orders will help you fine-tune the execution process. The three main order types include market, limit, and stop orders, and you’re about to learn how they differ and how you can use them properly. These orders help you find the right time to enter [...]

This 11% yielding dividend stock offers massive income and a 2026 rebound case built around rising cash flow, growth, and lower leverage.

An analyst chopped his price target on the company's shares.

Enbridge has rewarded investors with strong gains and dependable dividends, but is there still enough upside left to justify buying the stock in 2026?

Ocugen (NASDAQ:OCGN) outlined plans to advance three late-stage retinal disease programs, with company speaker Shankar saying the company is targeting biologics license applications for retinitis pigmentosa and Stargardt disease next year and a third BLA for geographic atrophy in 2028. Speaking dur

The average 55-year-old Canadian still has plenty of TFSA room left. Here are two dividend stocks that could help make the most of it.

A stake worth around $6 billion was sold on Thursday.

The stablecoin issuer just got a federal stamp of legitimacy. The stock's problem, however, lies elsewhere.

So far, Pfizer has been an also-ran in the GLP-1 race, but that could change if its long-acting weight-loss medication takes off.

Investors were digesting the specialty food company's latest earnings report.

What does this change for Circle stock?

Nyxoah (NASDAQ:NYXH) used its investor day presentation to outline early U.S. launch progress for its Genio hypoglossal nerve stimulation system, address reimbursement questions and describe its path toward profitability. Chief Executive Officer Olivier Taelman said there is “a lot of excitement in

Alimentation Couche-Tard (TSX:ATD) might be the perfect TFSA stock to own for life.

Gold and Bitcoin have been in a funk, and so has this global consumer staples giant, but a business can grow.

The company's AI strategy is beginning to pay dividends.

Netskope (NASDAQ:NTSK) held its annual meeting of stockholders virtually on July 7, 2026, with shareholders approving both proposals presented by the company, according to remarks made during the meeting. Sanjay Beri, Netskope’s chairman of the board, chief executive officer and co-founder, called

A media report stated it was the subject of a buyout offer.

C3.ai's revenue has plummeted in 2026 while BigBear.ai holds steady — and the gap between them is shrinking.

Figma's stock lost more than half its value in six months. Strong earnings couldn't overcome fears about AI-native competition.

On July 10, 2026, stock gained on renewed confidence as the S&P 500 edged back toward record highs.

It's been a volatile year for the company, but don't let that scare you away.

The pullback has created an attractive entry point for investors seeking a high-quality dividend stock with an over 4.6% yield.

XLE's lower costs and higher yields appeal to value investors, while ICLN's global renewable exposure attracts those betting on the energy transition.

BNS could look like a “turnaround dividend bank” now, but a “credible total-return bank” by 2029 if returns keep improving.

This TFSA dividend stock pays investors monthly cash flow, trades below its true value, and just posted record production. Here's the full breakdown.